November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
November 16, 2023 VCP Disease(s), an Integrated Approach to Neurodegenerative Disorders In this webinar from Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), speake
November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica
November 30, 2023 2023 C-Path Neuroscience Annual Meeting C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders....
C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
November 7, 2023 C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce
eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac
October 26, 2023 C-Path and Congenital Hyperinsulinism International Announce Data Sharing Agreement TUCSON, Ariz., October 26, 2023 — Critical Path Institute (C-Path) and Congenital Hyperinsulinism International (CHI), a leading
October 25, 2023 C-Path Announces Significant Expansion in Neonatal RWD Project Details of the expansion will be a highlight of the Institute’s Scientific Breakthrough Summit Oct. 26-27 in D.C. TUCSON, Ariz.,